Samuel L Aitken

21PUBLICATIONS
46CO-AUTHORS
Medical bacteriologyClinical pharmacy and pharmacy practicePharmacogenomicsMedical infection agents (incl. prions)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jun 10, 2026
Clinical Impact of Linezolid Therapeutic Drug Monitoring on the Tolerability of Prolonged Courses in the Outpatient Setting.

|Nov 18, 2025
First Report of Treatment-Emergent Resistance to Cefepime-Zidebactam in Pseudomonas aeruginosa.

Ava J Dorazio, Samuel L Aitken, Virginia M Pierce

|Apr 22, 2025
Antimicrobial Stewardship and Beyond: The Many Essential Roles of Infectious Diseases Pharmacists.

Wesley D Kufel, Conan MacDougall, Samuel L Aitken

|Nov 25, 2024
A Comparison of Different Strategies for Optimizing the Selection of Empiric Antibiotic Therapy for Pneumonia Caused by Gram-Negative Bacteria in Intensive Care Units: Unit-Specific Combination Antibiograms Versus Patient-Specific Risk Factors.

Walaiporn Wangchinda, Samuel L Aitken, Megan E Klatt

|Apr 25, 2024
The Growing Threat of NDM-Producing Escherichia coli With Penicillin-Binding Protein 3 Mutations in the United States-Is There a Potential Role for Durlobactam?

Samuel L Aitken, Virginia M Pierce, Jason M Pogue

|Jan 05, 2024
Structural insights into the molecular mechanism of high-level ceftazidime-avibactam resistance conferred by CMY-185.

Akito Kawai, William C Shropshire, Masahiro Suzuki

Pageof 4

Frequent Collaborators

5 joint publications

Samuel A Shelburne

4 joint publications

William C Shropshire

3 joint publications

Micah M Bhatti

3 joint publications

Ryan K Shields